Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.85B | $1.87B | $7.37B | $1.91B | $1.89B |
| Total Operating Revenue | $2.17B | $2.24B | $8.52B | $2.24B | $2.31B |
| Cost of Revenue | $1.26B | $1.22B | $5.28B | $1.51B | $1.24B |
| Gross Profit | $907.13M | $1.03B | $3.24B | $737.26M | $1.06B |
| Operating Expense | $129.45M | $126.29M | $545.93M | $133.12M | $128.89M |
| Selling and Admin Expenses | $129.45M | $126.29M | $545.93M | $133.12M | $128.89M |
| -Selling & Marketing Expense | $20.55M | $22.55M | $76.87M | $16.98M | $18.98M |
| -General & Admin Expense | $108.90M | $103.74M | $469.06M | $116.14M | $109.90M |
| Operating Profit | $777.68M | $899.10M | $2.69B | $604.15M | $935.74M |
| Other Income (Expense) | $17.57M | -$4.79M | $1.40B | $25.45M | $430.76M |
| Gain on Sale of Security | -$2.94M | -$926,000.00 | $13.28M | $38.95M | -$1.73M |
| Special Income (Charges) | $20.51M | -$3.86M | $1.38B | -$13.50M | $432.50M |
| -Less:Impairment of Capital Assets | $8.69M | $5.87M | $98.84M | $51.50M | $41.73M |
| -Less:Other Special Charges | -$29.19M | -$2.01M | -$1.48B | -$38.01M | -$474.22M |
| Pretax Profit | $795.25M | $894.31M | $4.09B | $630.03M | $1.37B |
| Tax | $123.12M | $138.62M | $555.25M | $77.66M | $198.25M |
| Earnings from Equity Interest Net of Tax | $53.59M | $62.43M | $213.85M | $80.44M | $47.48M |
| Net Profit | $725.72M | $818.13M | $3.75B | $632.81M | $1.22B |
| Profit from Continuing Operations | $725.72M | $818.13M | $3.75B | $632.81M | $1.22B |
| Minority Interests | -$2,000.00 | -$2,000.00 | $2,000.00 | $10,000.00 | -$9,000.00 |
| Net Income to Parent Company | $725.72M | $818.13M | $3.75B | $632.80M | $1.22B |
| Net Income to Common Stockholders | $725.72M | $818.13M | $3.75B | $632.80M | $1.22B |
| Basic EPS | $4.65 | $5.06 | $21.78 | $3.86 | $7.09 |
| Diluted EPS | $4.59 | $4.96 | $21.30 | $3.79 | $6.98 |
| Dividend Per Share | $0.40 | $0.40 | $1.08 | $0.27 | $0.27 |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $71.18B | $71.42B | $71.67B | $71.67B | $71.94B |
| Total Current Assets | $5.88B | $6.07B | $6.12B | $6.12B | $5.56B |
| Cash and Cash Equivalents & Short-Term Investments | $1.69B | $1.48B | $1.38B | $1.38B | $1.81B |
| -Cash and Cash Equivalents | $1.69B | $1.48B | $1.38B | $1.38B | $1.81B |
| Receivables | $3.58B | $3.49B | $3.42B | $3.42B | $2.96B |
| -Accounts Receivable | $76.75M | $55.76M | $48.50M | $48.50M | $62.37M |
| -Loans Receivable | $91.02M | $88.61M | $86.85M | $86.85M | $547.27M |
| -Notes Receivable | $530.36M | $493.34M | $513.69M | $513.69M | – |
| -Other Receivables | $2.88B | $2.85B | $2.77B | $2.77B | $2.36B |
| Inventory | $90.82M | $102.26M | $112.44M | $112.44M | $118.63M |
| Restricted Cash | $113.05M | $102.66M | $100.56M | $100.56M | $98.17M |
| Total Non-Current Assets | $65.31B | $65.35B | $65.55B | $65.55B | $66.38B |
| Net PPE | $62.03B | $61.99B | $62.11B | $62.11B | $62.30B |
| -Gross PPE | $78.67B | $78.41B | $78.23B | $78.23B | $78.44B |
| -Accumulated Depreciation | -$16.64B | -$16.42B | -$16.12B | -$16.12B | -$16.15B |
| Investments and Advances | $1.42B | $1.37B | $1.36B | $1.36B | $1.25B |
| -Long Term Equity Investment | $1.41B | $1.36B | $1.32B | $1.32B | $1.23B |
| Financial Assets | $32.34M | $18.77M | $12.25M | $12.25M | $20.15M |
| Goodwill and Other Intangible Assets | $1.55B | $1.70B | $1.80B | $1.80B | $1.89B |
| -Other Intangible Assets | $1.55B | $1.70B | $1.80B | $1.80B | $1.89B |
| Non-Current Deferred Assets | $170.33M | $171.50M | $172.88M | $172.88M | $262.15M |
| Other Non-Current Assets | $101.99M | $107.75M | $100.40M | $100.40M | $572.76M |
| Total Liabilities | $52.77B | $53.02B | $53.35B | $53.35B | $53.79B |
| Total Current Liabilities | $1.70B | $1.73B | $1.78B | $1.78B | $1.77B |
| Payables | $869.81M | $911.09M | $934.77M | $934.77M | $911.52M |
| -Accounts Payable | $869.81M | $911.09M | $934.77M | $934.77M | $911.52M |
| Current Deferred Liabilities | $830.76M | $821.39M | $840.94M | $840.94M | $862.96M |
| Total Non-Current Liabilities | $51.07B | $51.29B | $51.57B | $51.57B | $52.01B |
| Long Term Debt and Capital Lease Obligation | $42.82B | $43.09B | $43.61B | $43.61B | $44.08B |
| -Long Term Debt | $42.77B | $43.04B | $43.57B | $43.57B | $44.03B |
| -Long Term Capital Lease Obligation | $45.09M | $45.91M | $48.96M | $48.96M | $51.45M |
| Derivative Product Liabilities | $13.85M | $38.06M | $72.73M | $72.73M | $75.05M |
| Non-Current Liabilities | $3.66B | $3.63B | $3.53B | $3.53B | $3.49B |
| Non-Current Deferred Liabilities | $3.40B | $3.29B | $3.17B | $3.17B | $3.22B |
| Other Non-Current Liabilities | $1.18B | $1.24B | $1.19B | $1.19B | $1.15B |
| Total Equity | $18.41B | $18.40B | $18.32B | $18.32B | $18.15B |
| Stockholders' Equity | $18.41B | $18.40B | $18.32B | $18.32B | $18.15B |
| Capital Stock | $2.16M | $2.21M | $2.27M | $2.27M | $2.35M |
| -Common Stock | $2.16M | $2.21M | $2.27M | $2.27M | $2.35M |
| Additional Paid-In Capital | $2.43B | $2.93B | $3.52B | $3.52B | $4.19B |
| Retained Earnings | $17.72B | $17.07B | $16.32B | $16.32B | $15.73B |
| Less: Treasury Stock | $1.76B | $1.59B | $1.47B | $1.47B | $1.72B |
| Gains/Losses Not Affecting Retained Earnings | $12.95M | -$17.56M | -$50.21M | -$50.21M | -$54.01M |
| Minority Interests | $207,000.00 | $209,000.00 | $211,000.00 | $211,000.00 | $201,000.00 |
| Non-Current Note Receivables | – | – | – | – | $92.42M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.46B | $1.43B | $5.39B | $1.22B | $1.51B |
| Net cash flow from continuing operations | $1.46B | $1.43B | $5.39B | $1.22B | $1.51B |
| Net Income from Continuing Operations | $725.72M | $818.13M | $3.75B | $632.81M | $1.22B |
| Gain/Loss from Continuing Operations | -$221.07M | -$291.60M | -$827.83M | -$264.44M | -$355.29M |
| Depreciation & Depletion & Amortization | $641.74M | $639.02M | $2.65B | $653.02M | $665.48M |
| Deferred Tax | $105.44M | $120.63M | $501.50M | $39.17M | $195.58M |
| Other Non-Cash Items | $109.72M | $106.92M | -$1.45B | $2.88M | -$570.03M |
| Change in Working Capital | -$48.51M | -$56.77M | $343.73M | $44.56M | $220.36M |
| -Change in Receivables | -$22.89M | -$8.24M | $19.54M | $9.87M | -$4.09M |
| -Change in Payables and Accrued Expense | -$57.60M | -$12.47M | -$15.98M | -$10.95M | $20.14M |
| -Change in Other Current Assets | $31.98M | -$36.06M | $340.18M | $45.63M | $204.31M |
| Net cash flow from investing | -$240.74M | -$183.24M | -$1.66B | -$916.33M | $550.80M |
| Net Cash Flow from Continuing Investing Activities | -$240.74M | -$183.24M | -$1.66B | -$916.33M | $550.80M |
| Net PPE Purchase and Sale | -$1.32B | -$1.50B | -$6.07B | -$2.08B | -$1.02B |
| Net Other Investing Changes | $1.08B | $1.32B | $4.41B | $1.17B | $1.57B |
| Financing Cash Flow | -$1.00B | -$1.15B | -$3.65B | -$736.74M | -$2.99B |
| Net Cash Flow from Continuing Financing Activities | -$1.00B | -$1.15B | -$3.65B | -$736.74M | -$2.99B |
| Net Issuance Payments Of Debt | -$275.53M | -$519.67M | -$1.73B | -$452.19M | -$2.10B |
| Net Common Stock Issuance | -$739.56M | -$744.21M | -$2.54B | -$466.37M | -$967.61M |
| Cash Dividends Paid | -$61.79M | -$64.90M | -$192.44M | -$50.66M | -$46.42M |
| Net Other Financing Charges | $75.41M | $182.18M | $808.45M | $232.48M | $121.65M |
| Ending Cash Balance | $1.80B | $1.58B | $1.48B | $1.48B | $1.91B |
| Net Change in Cash | $215.87M | $101.88M | $75.53M | -$432.56M | -$933.28M |
| Beginning Cash Balance | $1.58B | $1.48B | $1.40B | $1.91B | $2.85B |
| Effect of Exchange Rate Changes | $1.23M | $693,000.00 | $2.63M | -$151,000.00 | -$424,000.00 |
| Free Cash Flow | $139.34M | -$69.91M | -$681.17M | -$861.44M | $484.74M |
No comments yet — be the first to weigh in on AER.